Angelo Di Leo cut his research teeth on the first studies that looked for biological markers that could predict which patients respond to what, and he’s never looked back.
Angelo Di Leo: mapping the geography of breast cancer
Marc Beishon
Related Articles
Drug Watch
Beyond the Herceptin hype
Featured
Farewell to chemotherapy?
Senza categoria